129 related articles for article (PubMed ID: 18414004)
1. Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.
Lee JS; Lee JY; Lee MY; Hwang DH; Youn HS
Mol Cells; 2008 Apr; 25(2):253-7. PubMed ID: 18414004
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
3. HIV protease inhibitor saquinavir inhibits toll-like receptor 4 activation by targeting receptor dimerization.
Yao K; Wang Z; Peng C; Wang Y; Xue B; Tang Y; Wang Z; Xu H
Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):754-760. PubMed ID: 37485845
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
6. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
7. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
[TBL] [Abstract][Full Text] [Related]
10. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
12. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.
Cusson-Hermance N; Khurana S; Lee TH; Fitzgerald KA; Kelliher MA
J Biol Chem; 2005 Nov; 280(44):36560-6. PubMed ID: 16115877
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia Attenuates Colonic Innate Immune Response and Inhibits TLR4/NF-κB Signaling Pathway in Lipopolysaccharide-Induced Colonic Epithelial Injury Mice.
Han Y; Jia R; Zhang J; Zhu Q; Wang X; Ji Q; Zhang W
J Interferon Cytokine Res; 2023 Jan; 43(1):43-52. PubMed ID: 36603105
[TBL] [Abstract][Full Text] [Related]
14. Anesthetic agent propofol inhibits myeloid differentiation factor 88-dependent and independent signaling and mitigates lipopolysaccharide-mediated reactive oxygen species production in human neutrophils in vitro.
Ren X; Lv F; Fang B; Liu S; Lv H; He G; Ma H; Cao Y; Wang Y
Eur J Pharmacol; 2014 Dec; 744():164-72. PubMed ID: 25446563
[TBL] [Abstract][Full Text] [Related]
15. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
[TBL] [Abstract][Full Text] [Related]
16. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
17. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
18. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
Zenke K; Muroi M; Tanamoto KI
Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
[TBL] [Abstract][Full Text] [Related]
19. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization.
Youn HS; Lee JK; Choi YJ; Saitoh SI; Miyake K; Hwang DH; Lee JY
Biochem Pharmacol; 2008 Jan; 75(2):494-502. PubMed ID: 17920563
[TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenergic receptor regulate Toll-like receptor 4-induced late-phase NF-kappaB activation.
Kizaki T; Shirato K; Sakurai T; Ogasawara JE; Oh-ishi S; Matsuoka T; Izawa T; Imaizumi K; Haga S; Ohno H
Mol Immunol; 2009 Mar; 46(6):1195-203. PubMed ID: 19167076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
